Novo Nordisk is launching a weight-loss pill price war as it seeks to keep pace with arch-rival Eli Lilly in the market for GLP-1 drugs.
The Danish drugmaker announced on Monday that patients could purchase the lowest 1.5mg and 4mg doses of its Wegovy pill for $149 a month in the US until April, when the 4mg dose will rise to $199 a month. Patients with insurance can pay as little as $25 a month for the lowest doses.
Higher doses of the drug at 9mg and 25mg are priced at $299 for a month-long supply.
您已阅读22%（503字），剩余78%（1760字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。